Key result
Hepatic vein A-wave reversal velocity predicts ~13% higher odds of elevated RV filling pressures in pediatric PAH.
Why the study?
Do echocardiographic diastolic parameters accurately predict invasively measured elevated right ventricular filling pressures in pediatric pulmonary arterial hypertension?
Observational (n=143)
Yes
Do echocardiographic diastolic parameters accurately predict invasively measured elevated right ventricular filling pressures in pediatric pulmonary arterial hypertension?
While hepatic vein A-wave reversal velocity is the best echocardiographic predictor of elevated right ventricular filling pressures in pediatric PAH, echocardiographic parameters overall remain inadequate surrogates for invasive measurements.
May support noninvasive RVFP estimation in pediatric PAH; leaves open prospective validation before clinical adoption.
BACKGROUND Increased right ventricular filling pressures (RVFP) are associated with increased mortality risk in children with pulmonary arterial hypertension (PAH). We aimed to investigate the correlation of echocardiographic diastolic parameters with invasive measurements of RVFP in pediatric PAH. METHODS We retrospectively reviewed 95 patients and 48 controls from the Hospital for Sick Children in Toronto and Children's Hospital Colorado. RV filling pressures (RVFP) were considered elevated when RV end-diastolic pressures (RVEDP) ≥8 mmHg or mean right atrial pressure (mRAP) >8 mmHg from the catheter. Echocardiographic measurements included hepatic vein A-wave reversal (HVA) velocity and duration, the ratio between HVA and HV systolic velocity (HV A/S), indexed right atrial volume (RAVi), and RV and RA diastolic strains. Logistic regression and receiver operating characteristic curve analysis were used to investigate the predictive value of echo parameters for elevated RVFP. RESULTS PAH patients had significantly elevated HVA velocity, duration and HV A/S, enlarged RAVi, and decreased RA and RV strains. HVA velocity had the highest area under the receiver operating characteristic curve (AUC) for diagnosing elevated RVFP [AUC = 0.788 (0.570-1), p = 0.021]. The model with HVA velocity significantly predicted elevated RVFP [Nagelkerke R2 = 0.339, B(SE) = 0.121 (0.06), odds ratio = 1.129 (1.003-1.27), p = 0.044)]. CONCLUSIONS Of the echo parameters studied, HVA velocity was the best predictor of elevated RVFP in pediatric PAH. But in general, echocardiographic parameters were inadequate indicators of RVFP. Further prospective studies in a larger cohort are needed to determine the association between HV Doppler and changes in RVFP, and ultimately with clinical outcomes.
No takes yet. Share an insight, caveat, or question.
Palmert et al. (2026) conducted an observational in Pediatric pulmonary arterial hypertension (n=143). Hepatic vein A-wave reversal velocity vs. Invasive right ventricular filling pressures was evaluated on Elevated right ventricular filling pressures (RVEDP ≥8 mmHg or mRAP >8 mmHg) (OR 1.129, 95% CI 1.003-1.27, p=0.044). Hepatic vein A-wave reversal velocity significantly predicted elevated right ventricular filling pressures in pediatric pulmonary arterial hypertension (OR 1.129; 95% CI 1.003-1.27; p=0.044).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: